(Alliance News) - Clinical stage biotechnology firm ValiRx PLC said on Tuesday it has received an HMRC research & development tax credit of GBP423,000.
The company said it continues to "carefully manage" its working capital position.
Shares in ValiRx were up 7.6% at 0.1667 pence in London on Tuesday.
By Lucy Heming; firstname.lastname@example.org
Copyright 2019 Alliance News Limited. All Rights Reserved.